TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 54 filers reported holding TOKAI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,000 | -72.7% | 6,000 | 0.0% | 0.00% | -75.0% |
| Q2 2016 | $33,000 | -2.9% | 6,000 | 0.0% | 0.01% | -20.0% |
| Q1 2016 | $34,000 | -34.6% | 6,000 | 0.0% | 0.02% | -34.8% |
| Q4 2015 | $52,000 | -16.1% | 6,000 | 0.0% | 0.02% | -30.3% |
| Q3 2015 | $62,000 | -22.5% | 6,000 | 0.0% | 0.03% | -23.3% |
| Q2 2015 | $80,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 637,110 | $3,574,187,000 | 0.71% |
| Novo Holdings A/S | 470,946 | $2,642,000 | 0.29% |
| Perceptive Advisors | 485,338 | $2,723,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 812,200 | $4,556,000 | 0.23% |
| FNY Managed Accounts LLC | 6,438 | $36,117,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $271,000 | 0.06% |
| Alyeska Investment Group, L.P. | 315,757 | $1,771,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $34,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $337,000 | 0.01% |
| BlackRock Fund Advisors | 530,538 | $2,976,000 | 0.00% |